Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against cisplatin-induced acute kidney injury
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against cisplatin-induced acute kidney injury
Authors
Keywords
-
Journal
CLINICAL SCIENCE
Volume 132, Issue 7, Pages 825-838
Publisher
Portland Press Ltd.
Online
2018-03-27
DOI
10.1042/cs20171625
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD
- (2016) R. Provenzano et al. Clinical Journal of the American Society of Nephrology
- The Hypoxia-inducible Factor Prolyl-Hydroxylase Inhibitor Roxadustat (FG-4592) and Warfarin in Healthy Volunteers: A Pharmacokinetic and Pharmacodynamic Drug–Drug Interaction Study
- (2016) Dorien Groenendaal-van de Meent et al. CLINICAL THERAPEUTICS
- Comparative systems pharmacology of HIF stabilization in the prevention of retinopathy of prematurity
- (2016) George Hoppe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients
- (2015) Anatole Besarab et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Acute kidney injury—epidemiology, outcomes and economics
- (2014) Oleksa Rewa et al. Nature Reviews Nephrology
- Physiology and Pharmacology of Erythropoietin
- (2014) Wolfgang Jelkmann TRANSFUSION MEDICINE AND HEMOTHERAPY
- Pan-genomic binding of hypoxia-inducible transcription factors
- (2013) Johannes Schödel et al. BIOLOGICAL CHEMISTRY
- Amelioration of cisplatin-induced mouse renal lesions by a cyclooxygenase (COX)-2 selective inhibitor
- (2013) Shigeyoshi Honma et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Tubular von Hippel-Lindau Knockout Protects against Rhabdomyolysis-Induced AKI
- (2013) M. Fahling et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Regulation of hypoxia-inducible factor in kidney disease
- (2012) Masaomi Nangaku et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Section 3: Prevention and Treatment of AKI
- (2012) Kidney International Supplements
- Celecoxib, a Selective Cyclooxygenase-2 Inhibitor, Attenuates Renal Injury in a Rat Model of Cisplatin-Induced Nephrotoxicity
- (2011) Ghada M. Suddek et al. CHEMOTHERAPY
- Erythropoietin (EPO) in acute kidney injury
- (2011) Elizabeth Moore et al. Annals of Intensive Care
- Amelioration of cisplatin nephrotoxicity by genetic or pharmacologic blockade of prostaglandin synthesis
- (2010) Zhanjun Jia et al. KIDNEY INTERNATIONAL
- Alpha-lipoic acid attenuates cisplatin-induced acute kidney injury in mice by suppressing renal inflammation
- (2009) K. P. Kang et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Diagnosis, Epidemiology and Outcomes of Acute Kidney Injury
- (2008) S. S. Waikar et al. Clinical Journal of the American Society of Nephrology
- Acute kidney injury
- (2008) John A. Kellum CRITICAL CARE MEDICINE
- HIF Activation Protects From Acute Kidney Injury
- (2008) A. Weidemann et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now